 II. Determine the side effects of this regimen in these patients. III. Correlate soluble activated endothelial cell markers and adhesion molecules, quantitation of tumor andor endothelial cell apoptosis, and quantitation of microvessel density with clinical outcome in patients treated with this regimen. 